Gilead Sciences on Wednesday said its experimental single-tablet HIV treatment was generally well tolerated with low ...

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could ...

The Philadelphia HIV Resource Finder allows Philadelphians to search for treatment and prevention resources throughout the city.

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

A single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich ...

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively ...

A Ugandan court awarded John Wataka 190 million shillings after TASO's negligence led to a wrongful HIV diagnosis, causing ...

Researchers here presented what they said is the first evidence demonstrating that benefits paid through the Supplemental Nutrition Assistance Program, or SNAP, can improve a person’s adherence to HIV ...

TACLOBAN CITY – The island town of Biri in Northern Samar has opened an HIV Treatment Hub to strengthen healthcare service ...

A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...